The SH-SY5Y cell line: a valuable tool for Parkinson's disease drug discovery

M Pandey, V Karmakar, A Majie… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Owing to limited efficient treatment strategies for highly prevalent and
distressing Parkinson's disease (PD), an impending need emerged for deciphering new …

[HTML][HTML] Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease

LD Skou, SK Johansen, J Okarmus, M Meyer - Cells, 2024 - mdpi.com
Parkinson's disease (PD) is a common movement disorder associated with the degeneration
of dopaminergic neurons in the substantia nigra pars compacta. Mutations in the PD …

Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell

Y Jia, M Oyken, RQ Kim, RTN Tjokrodirijo… - Journal of Medicinal …, 2024 - ACS Publications
The integration of diverse chemical tools like small-molecule inhibitors, activity-based
probes (ABPs), and proteolysis targeting chimeras (PROTACs) advances clinical drug …

Chaperone-Mediated Autophagy in Brain Injury: A Double-Edged Sword with Therapeutic Potentials

H Zhang, Y Tian, S Ma, Y Ji, Z Wang, P Xiao… - Molecular …, 2024 - Springer
Autophagy is an intracellular recycling process that maintains cellular homeostasis by
degrading excess or defective macromolecules and organelles. Chaperone-mediated …

[HTML][HTML] The major histocompatibility complex participates in Parkinson's disease

R Gu, J Pan, MUN Awan, X Sun, F Yan, L Bai… - Pharmacological …, 2024 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative disease characterized by
progressive loss of dopaminergic neurons in the substantia nigra and the aggregation of …

[HTML][HTML] A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning

MA Patel, M Daley, LR Van Nynatten, M Slessarev… - Clinical Proteomics, 2024 - Springer
Background COVID-19 is a complex, multi-system disease with varying severity and
symptoms. Identifying changes in critically ill COVID-19 patients' proteomes enables a better …

[HTML][HTML] Mitochondrial and Nuclear DNA Variants in Amyotrophic Lateral Sclerosis: Enrichment in the Mitochondrial Control Region and Sirtuin Pathway Genes in …

SN Cox, C Lo Giudice, A Lavecchia, ML Poeta… - Biomolecules, 2024 - mdpi.com
Amyotrophic Lateral Sclerosis (ALS) is a progressive disease with prevalent mitochondrial
dysfunctions affecting both upper and lower motor neurons in the motor cortex, brainstem …

PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation

FLH Mogensen, C Sousa, C Ameli, K Badanjak… - 2024 - researchsquare.com
Background Specific microglia responses are thought to contribute to the development and
progression of neurodegenerative diseases, including Parkinson's disease (PD). However …

[PDF][PDF] Investigating the interplay between the Parkinson's Disease proteins VPS35 and LRRK2 in an isogenic cell model system

K McCarron - 2023 - livrepository.liverpool.ac.uk
Abstract In familial Parkinson's Disease (PD), which makes up 10-15% of all PD cases,
causative mutations in seventeen genes have been discovered. Study of these genes has …

[PDF][PDF] Design, synthesis and biological evaluation of tool compounds for the cellular investigation of deubiquitinases

M Schmidt - 2023 - eldorado.tu-dortmund.de
The results in this thesis were developed in collaboration with Dr. Christian Grethe. This
thesis discusses and illustrates data from Dr. Christian Grethe to understand the process of …